Amikacin
Amikacin is a broad-spectrum aminoglycoside antibiotic used to treat serious bacterial infections caused by susceptible organisms, particularly certain Gram-negative bacteria. It is commonly used for severe infections such as complicated urinary tract infections, lower respiratory tract infections, bloodstream infections, intra-abdominal infections, and selected hospital-acquired infections. Amikacin works by binding to the bacterial 30S ribosomal subunit, interfering with protein synthesis and inhibiting bacterial growth. It is generally administered by intravenous infusion or intramuscular injection under medical supervision. Important adverse effects include kidney toxicity (nephrotoxicity), hearing or balance damage (ototoxicity), and, rarely, neuromuscular blockade. Kidney function and, when indicated, blood drug concentrations and hearing should be monitored during treatment. Amikacin should be used judiciously according to susceptibility testing and antimicrobial stewardship guidance.
Amikacin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Amikacin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Amikacin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Amikacin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
